8V8Genetic Analysis AS8V8 info
$0.03info-12.77%24h
Global rank
Market cap$987.59K
Change 7d-13.99%
YTD Performance-58.59%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Genetic Analysis AS (8V8) Stock Overview

    Genetic Analysis AS, a science-based diagnostic company, develops diagnostic solutions for human microbiome market. It offers GA-map Dysbiosis Test Lx, a molecular assay for profiling the gut microbiota to identify and characterize dysbiosis for treating patients with Irritable Bowel Syndrome, Inflammatory Bowel Disease, diabetes type 2, gut disorder, lifestyle diseases, and leaky-gut syndrome; GA-map COVID-19 Fecal Test Kit, a qualitative real time standardized PCR test for the detection of the 2019 novel coronavirus RNA in stool samples; GA-map Dysbiosis Test reagent kit, a CE-IVD documented test, which is a software that performs QC on the run file, calculates the dysbiosis index score and abundance table, and converts sample result into reports; and GA-map Covid fecal test reagent kit, a CE-IVD documented test to detect SARS-CoV-2 in fecal samples. The company was founded in 2008 and is headquartered in Oslo, Norway.

    8V8 Stock Information

    Symbol
    8V8
    Address
    Kabelgata 8Oslo, 0580Norway
    Founded
    -
    Trading hours
    -
    Website
    https://www.genetic-analysis.com
    Country
    🇳🇴 Norway
    Phone Number
    47 48 32 16 10

    Genetic Analysis AS (8V8) Price Chart

    -
    Value:-

    Genetic Analysis AS Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.02585364210570567
    N/A
    Market Cap
    $987.59K
    N/A
    Shares Outstanding
    38.20M
    N/A
    Employees
    22.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org